Laboratory articles

1. Gallicchio, MA and Bach, LA. Uptake of Advanced Glycation End Products by proximal tubule epithelial cells via macropinocytosis. Biochim Biophys Res Commun Mol Cell Res 2013; 1833: 2922–2932

2. Chunyang Zhang, Ling Lu, Xianlei Wang, Yun Li, Yuanzhang Liu, Ping Fu, Marisa A Gallicchio, Leon A Bach and Cunming Duan. Induction of IGFBP-6 in vascular endothelial cells is a component of a conserved negative feedback mechanism in hypoxia-induced tumor angiogenesis. Int J Cancer 2011 May 1; 130(9): 2003–2012

3. Gallicchio MA and Bach, LA. Advanced glycation end products inhibit Na+K+ATPase in proximal tubule cells: role of cPLA2α and phosphatidylinositol 4-phosphate 5-kinase. Biochim Biophys Res Commun Mol Cell Res 2010; 1803: 919–930

4. Gallicchio MA, McRobert EA, Tikoo A, Cooper ME, Bach LA. Ezrin overexpression inhibits the effects of advanced glycation endproducts on tubulogenesis and migration. J Am Soc Nephrol 2006; 17: 414–421

5. McRobert EA, Gallicchio MA, Jerums G, Cooper ME, Bach LA. The amino terminal domains of ERM proteins bind AGEs: an interaction that may play a role in the development of diabetic complications. J Biol Chem 2003; 278: 25783–2578

6. Gallicchio MA, van Sinderin M, Bach LA. IGFBP-6 and CCI-779, an ester analog of rapamycin, additively inhibit rhabdomyosarcoma growth. Horm Met Res 2003;5:822–827

7. Gallicchio MA, Kaun C, Wojta J, Binder B, Bach LA. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro. J Cell Physiol 2003; 197: 131–138

8. Gallicchio MA, Kneen M, Hall C, Scott AM, Bach LA. Overexpression of insulin-like growth factor binding protein-6 inhibits rhabdomyosarcoma growth in vivo. Int J Cancer 2001; 94: 645–651

9. Gallicchio M, McFarlane J, Hufnagl P, Holdsworth S, Tipping P. Stimulation of PAI-1 in rabbit anti-GBM glomerulonephritis. Nephrology 1998; 4: 65–74

10. Gallicchio M, Hufnagl P, Wojta J, Tipping P. Downregulation of thrombin- and endotoxin-induced plasminogen activator inhibitor type 1 in cultured human endothelial cells by interferon-gamma. J Immunol 1996; 157: 2610–2617

11. Gallicchio M, Wojta J, Hamilton JA, McGrath K. Regulation of plasminogen activator inhibitor type 1 in cultured smooth muscle cells by interleukin 1-alpha and tumor necrosis factor-alpha. Fibrinolysis 1995; 9: 145–151

12. Gallicchio M, Filonzi EL, Zoellner H, Hamilton JA, McGrath K, Wojta J. Stimulation of plasminogen activator inhibitor type-1 expression in endothelial cells by cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1994; 14: 815–823 

13. Wojta J, Zoellner H, Gallicchio M, Filonzi EL, Hamilton JA, McGrath K. Interferon-alpha2 counteracts interleukin-1alpha expression of uPA in human foreskin microvascular endothelial cells in vitro. Lymphokine Cytokine Res 1994; 13: 133–138

14. Hamilton JA, Wojta J, Gallicchio M, McGrath K, Filonzi EL. Contrasting effects of TGF-beta and IL-1 on the regulation of plasminogen activator inhibitors in human synovial fibroblasts. J Immunol 1993; 151: 5154–5161

15. Hamilton JA, Whitty GA, Wojta J, Gallicchio M, McGrath K, Ianches G. Macrophage colony stimulating and granulocyte macrophage colony stimulating factor stimulate synthesis of PAIs by human monocytes. Blood 1993; 82: 3616–3621

16. Hamilton JA, Whitty GA, Wojta J, Gallicchio M, McGrath K, Ianches G. Regulation of PAI-1 levels in human monocytes. Cell Immunol 1993; 152: 7–17

17. Liu J, Casley D, Wojta J, Gallicchio M, Dauer R, Johnston CI, Buxton BF. Effects of calcium and ETa-receptor antagonists on endothelin-induced vasoconstriction and levels of endothelin in the human mammary artery. Clin Exp Pharm Physiol 1994; 21: 49-57

18. Liu J, Casley D, Wojta J, Gallicchio M, Dauer R, Buxton C, Johnston C. Reduction of endothelin 1 levels by the dihydropyridine calcium antagonist nisoldinine and natural factor in cultured human endothelial cells. J Hypertension 1993; 11: 977–982

19. Wojta J, Gallicchio M, Zoellner H, Hamilton JA, McGrath K. Interleukin 4 stimulates expression of urokinase-type plasminogen activator in cultured human foreskin microvascular endothelial cells. Blood 1993; 81: 3285–3292

20. Wojta J, Gallicchio M, Zoellner H, Hufangl P, Last K, Binder B, Hamilton JA, McGrath K. Thrombin stimulates expression of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1) in cultured human vascular smooth muscle cells. Thromb Haemost 1993; 70: 469–474

21. Zoellner H, Wojta J, Gallicchio M, McGrath K, Hamilton JA. Synthesis of plasminogen activator inhibitor-2 by vascular endothelial cells in response to interleukin-1 and tumour necrosis factor alpha. Thromb Haemost 1993; 69: 135–140

22. Tipping PG, Davenport P, Gallicchio M, Filonzi EL, Apostolopoulos J, Wojta J. Atheromatous plaque macrophages produce PAI-1 and stimulate its production by endothelial cells and vascular smooth muscle cells. Am J Pathol 1993; 143: 875–885

23. Savige JA, Gallicchio M. IgA anti-myeloperoxidase antibodies associated with crescentic IgA glomerulonephritis. Nephrol Dial Transplant 1992; 7: 952–959

24. Wojta J, Zoellner H, Gallicchio M, Hamilton JA, McGrath K. Gamma-interferon counteracts interleukin-1-stimulated expression of urokinase-type plasminogen activator in human endothelial cells in vitro. Biochem Biophys Res Commun 1992; 188: 463–469

25. Hamilton JA, Cheung D, Filonzi EL, Piccoli DS, Wojta J, Gallicchio M, McGrath K, Last K. Independent regulation of plasminogen activator inhibitor 2 and plasminogen activator inhibitor 1 in human synovial fibroblasts. Arthritis Rhuem 1992; 35: 1526–1534

26. Gallicchio M, Savige JA. Detection of anti-myeloperoxidase and anti-elastase antibodies in vasculitides and infections. Clin Exp Immunol 1991; 84: 232–237

27. Savige JA, Gallicchio M. The non-collagenous domains of the alpha 3 and 4 chains of type IV collagen and their relationship to the Goodpasture antigen. Clin Exp Immunol 1991; 84: 454–458

28. Savige JA, Gallicchio M, Chang L, Parkin JD. Autoantibodies in systemic vasculitis. Aust NZ J Med 1991; 21: 433–437

29. Savige JA, Gallicchio M, Stockman A, Cunningham TJ, Rowley MJ, Georgiou T, Davies D. ANCA in rheumatoid arthritis. Clin Exp Immunol 1991; 86: 92–98

30. Savige JA, Gallicchio M, Baker C, Varigos G. Circulating anti-glomerular basement membrane antibodies in coeliac disease and epidermolysis bullosa acquisita. Aust NZ J Med 1991; 21: 867–870

31. Savige JA, Gallicchio M, Georgiou T, Davies DJ. Diverse target antigens recognized by circulating antibodies in anti-neutrophil cytoplasm antibody associated renal vasculitides. Clin Exp Immunol 1990; 82: 238–243

32. Savige JA, Yeung SP, Gallicchio M, Davies DJ. Two ELISAs to detect anti-neutrophil cytoplasm antibodies (ANCA) in various vasculitides. Pathology 1989; 21: 282–287

Review articles

1. Bach LA, Young A, Gallicchio MA, McRobert EA Glycated Proteins Bind to ERM Proteins and Modulate their Actions. The Maillard Reaction: Interface between Aging, Nutrition and Metabolism, eds. MC Thomas and J Forbes. August, 2010 p. 31–37

2. Bach LA, Gallicchio MA, McRobert EA, Tikoo A, Cooper ME. Effects of AGEs on ezrin-dependent functions in LLC-PK1 proximal tubule cells. In: Baynes J, Monnier V, Ames J, Thorpe S (eds.) The Maillard Reaction: Chemistry at the Interface of Nutrition, Aging, and Disease, Ann NY Acad Sci 1043: 609–616, 2005

3. McRobert EA, Tikoo A, Gallicchio MA, Cooper ME, Bach LA. Localization of the ezrin binding site for glycated proteins. In: Baynes J, Monnier V, Ames J, Thorpe S (eds.) The Maillard Reaction: Chemistry at the Interface of Nutrition, Aging, and Disease, Ann NY Acad Sci 1043: 617–624, 2005

Book chapters

1. Gallicchio M Ch 12 “Culture of human smooth muscle cells” in Atherosclerosis Experimental Methods and Protocols. Methods in Molecular Medicine ed. AF Drew Nov. 2000 p. 137–146

2. Gallicchio M Ch 13 “Culture of human endothelial cells” in Atherosclerosis Experimental Methods and Protocols. Methods in Molecular Medicine ed. AF Drew Nov. 2000 p. 147–161